GXAI.NASDAQGaxosai INC

10-Q: Gaxos.ai Inc. Reports Q1 2025 Results, Revenue Increases Driven by RNK Health

Sentiment:

Quarterly Report


Gaxos.ai Inc. reports increased revenue for Q1 2025, driven primarily by its RNK Health subsidiary, while continuing to invest in AI-powered health and gaming solutions.

Worse than expectedThe company's net loss increased compared to the same period last year.Operating expenses increased significantly, driven by higher research and development and general and administrative costs.

Summary

  • Gaxos.ai Inc. reported its financial results for the quarter ended March 31, 2025.
  • The company generated revenues of $23,732, a slight increase from $19 in the same period last year.
  • The revenue increase was primarily driven by RNK Health, which contributed $22,552 through non-clinical services.
  • The company's net loss for the quarter was $1,232,062, compared to a net loss of $912,145 in the prior year.
  • Operating expenses increased to $1,415,427 from $1,043,858, due to higher research and development and general and administrative costs.
  • As of March 31, 2025, Gaxos.ai had a cash balance of $2,571,340 and short-term investments of $12,116,298.
  • The company believes its existing working capital will be sufficient to meet its operating needs for the next twelve months.
  • Gaxos.ai is focused on developing AI-powered solutions in health and entertainment, including Gaxos Labs, Gaxos Gaming, and Gaxos Health.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While revenue increased, the company still reported a significant net loss and increased operating expenses. The company's future success depends on its ability to execute its growth strategy and obtain additional financing.

Positives

  • Revenue increased compared to the same period last year, driven by the RNK Health subsidiary.
  • The company has a significant amount of short-term investments.
  • The company believes its existing working capital and cash on hand will provide sufficient cash to enable the Company to meet its operating needs and debt requirements for the next twelve months from the issuance date of this report.

Negatives

  • The company experienced a net loss of $1,232,062 for the quarter.
  • Operating expenses increased significantly, driven by higher research and development and general and administrative costs.
  • The company has a history of operating losses and expects to continue generating operating losses in the foreseeable future.

Risks

  • The company's ability to obtain additional financing is uncertain.
  • The company's Medial Partners telehealth business could be adversely affected by ongoing legal challenges to their business model or by new state actions restricting their ability to provide the full range of services in certain states.
  • The company's ultimate success is dependent on its ability to obtain additional financing and generate sufficient cash flow to meet its obligations on a timely basis.

Future Outlook

The company expects to continue generating operating losses in the foreseeable future until it implements its growth strategy. The company believes its existing working capital and cash on hand will provide sufficient cash to meet its operating needs and debt requirements for the next twelve months.

Management Comments

  • We are committed to addressing the need for AI solutions in both health and entertainment.
  • Gaxos Health will integrate AI-driven insights with individual biometric data and health goals to create web and application based personalized wellness strategies for users.
  • We believe that this technology is not just a step but a leap forward in empowering individuals to take control of their health and longevity with AIs precision and intelligence.

Industry Context

Gaxos.ai operates in the competitive fields of AI-driven gaming and health solutions. The company's focus on integrating AI into gaming and health aligns with industry trends emphasizing personalized experiences and data-driven insights. Competitors include other AI-focused gaming companies and telehealth providers.

Comparison to Industry Standards

  • It is difficult to compare Gaxos.ai's results directly to industry standards due to its unique combination of AI, gaming, and health initiatives.
  • However, the company's revenue growth in the health sector can be compared to telehealth companies like Teladoc Health, which have seen significant growth in recent years.
  • In the gaming sector, companies like Unity and Epic Games are benchmarks for AI-driven content creation and user-generated content.
  • Gaxos.ai's success will depend on its ability to differentiate itself and capture market share in these competitive industries.

Stakeholder Impact

  • Shareholders will be concerned about the company's continued net losses and increased operating expenses.
  • Employees may be affected by the company's ability to secure additional financing and execute its growth strategy.
  • Customers may benefit from the company's development of AI-powered solutions in health and entertainment.

Next Steps

  • The company plans to pursue its plans with respect to the research and development of its products which will require resources beyond those that it currently have, ultimately requiring additional capital from third party sources.
  • The company will continue to focus on developing AI-powered solutions in health and entertainment.

Key Dates

DateDescription
2021-10-27Gaxos.ai Inc. was incorporated in Wyoming.
2022-03-30The Company reincorporated to the State of Delaware.
2024-01-05The Company changed its name from The NFT Gaming Company, Inc. to Gaxos.ai Inc.
2024-02-28A majority of the Company shareholders granted discretionary authority to the Companys Board of Directors to amend the Companys Certificate of Incorporation to effect one or more consolidations of the Companys issued and outstanding shares of common stock.
2024-03-03The Company reincorporated from The State of Delaware to the State of Nevada.
2024-03-04The Company entered into a Purchase Agreement with a third party to acquire certain technology and computer code.
2024-03-05The Company granted stock options to purchase an aggregate of 6,249 shares of the Companys common stock at an exercise price of $6.00 per share to the Companys board of directors pursuant to the 2022 Equity Incentive Plan.
2024-03-07The Company filed a Certificate of Amendment to the Amended and Restated Articles of Incorporation with the Secretary of State of the State of Delaware to effect a 1-for-12 reverse stock split with respect to the outstanding shares of the Companys common stock.
2024-03-07The Company entered into Advisory Board Agreements with three members of the Companys Medical Advisory Board.
2024-03-13The Company entered into a securities purchase agreement with an institutional investor for the issuance and sale in a private placement.
2024-05-16The Company purchased 666,660 common shares of RPM Interactive, Inc. for $199,998.
2024-05-28The Company granted options for an aggregate of 12,501 stock options at an exercise price of $3.82 per share to the Companys Advisory board pursuant to the 2022 Equity Incentive Plan.
2024-09-20The Company entered into an inducement offer agreement with the Holder of the March 2024 Common Warrants to immediately exercise for cash an aggregate 1,256,734 of the March 2024 Common Warrants to purchase shares of the Companys common stock at a reduced exercise price of $2.58 per share.
2024-09-23The Company formed a subsidiary, RNK Health, LLC.
2024-10-10The Company, RNK Health, and Nekwellness entered into a one-year RNK Health operating agreement.
2024-12-27At the Company annual meeting, the stockholders approved an amendment to the Companys Amended and Restated Certificate of Incorporation for the reincorporation of the Company from The State of Delaware to the State of Nevada.
2025-02-24The Company consummated a Software Purchase Agreement with a third party, whereby the Company purchased software and related technologies for $500,000 in cash and 200,000 shares of the Companys common stock.
2025-03-03The reincorporation of the Company from The State of Delaware to the State of Nevada occurred.
2025-03-31End of the quarterly period.
2025-04-14The Company granted stock options to purchase an aggregate of 75,000 shares of the Companys common stock at an exercise price of $1.11 per share to the Companys board of directors pursuant to the 2022 Equity Incentive Plan.
2025-05-13As of this date, there were 7,123,453 shares of common stock issued and outstanding.
2025-05-15Date of report filing.

Keywords

AI, Gaxos.ai, RNK Health, Financial Results, Q1 2025, Gaming, Health, Artificial Intelligence

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.